Avigen Employee Directory
Biotechnology ResearchUnited States11-50 Employees
Avigen is a United States–based biotechnology research company that operates with a relatively small team. It participates in the biotechnology research sector and has been involved in assets related to AAV, as evidenced by past transactions. In 2021, Avigen sold assets to MediciNova, specifically the rights to AAV assets, reflecting a shift in its asset portfolio. The information available does not detail current products or programs. A leadership change was noted in 2021, with John Monaghan retiring as chief executive officer in August. The available information places Avigen among smaller players in the U.S. biotech landscape, with history tied to AAV-related assets.